AVALON PHARMA - Latest News
SNB Capital issues Q2 2024 earnings estimates
Argaam 07/07/2024
Al Rajhi Capital issues Q2 2024 profit forecasts
Argaam 04/07/2024
Avalon Pharma EGM authorizes board to pay interim dividends for 2024
Argaam 01/07/2024
Here’s how top 50 Saudi-listed companies fared in Q1 2024
Argaam Special 30/05/2024
Avalon Pharma gets nod from SFDA to register new production lines
Argaam 06/05/2024
Senior execs of Aramco, SNB, eXtra, stc highest paid in 2023
Argaam Special 21/04/2024
Osool & Bakheet issues Q1 2024 earnings forecast
Argaam 20/04/2024
Highest-paid executives, board members of Saudi-listed firms in 2023
Argaam Special 16/04/2024
GIB Capital previews Q1 2024 earnings
Argaam 14/04/2024
Al Rajhi Capital issues Q1 profit forecasts for TASI-listed firms
Argaam 06/04/2024
GIB Capital initiates coverage on Avalon Pharma; sets rating, TP
Argaam 27/02/2024
Avalon Pharma debuts today as 2nd listing on TASI in 2024
Argaam Special 27/02/2024
SNB Capital initiates coverage on Avalon Pharma
Argaam 26/02/2024
Avalon Pharma to debut on Tadawul on Feb. 27
Argaam 25/02/2024
Edaa deposits Avalon Pharma subscribed shares into shareholder accounts
Argaam 25/02/2024
Forsa Capital expects Avalon Pharma share price to rise 23% post-listing
ِArgaam 30/01/2024
Retail subscription to 600,000 Avalon Pharma shares on TASI begins today
Argaam Special 30/01/2024
Avalon Pharma IPO: Subscription period, key dates
Argaam 30/01/2024
Here’s a list of receiving banks for Avalon Pharma’s IPO
Argaam 30/01/2024
Aldukheil Financial Group announces the coverage of Avalon Pharma’s offering for Participating Parties by 138.7 times
Argaam 24/01/2024
Avalon Pharma issues prospectus to list 6M shares on TASI
Argaam 07/01/2024
Avalon Pharma gets CMA’s nod to offer 30% stake on Tadawul
Argaam 06/12/2023